VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Regulatory challenges in automating CGT manufacturing

Delara Motlagh, PhD, MS, EMBA, Terumo Blood and Cell Technologies, Lakewood, CO, discusses hurdles associated with automating processes within the cell and gene therapy (CGT) field. Despite collaborative efforts between manufacturers and regulatory authorities, supply chain issues persist. Dr Motlagh additionally highlights the need for companies to fully understand every aspect of their current and future products. This interview took place at Advanced Therapies Week 2022.

Disclosures

Delara Motlagh, PhD, MS, EMBA, is an employee of Terumo Blood and Cell Technologies.